Resumen

MERTEN, Thomas et al. Symptom validity assessment in European countries: development and state of the art. Clínica y Salud [online]. 2013, vol.24, n.3, pp.129-138. ISSN 2174-0550.  https://dx.doi.org/10.5093/cl2013a14.

In the past, the practice of symptom validity assessment (SVA) in European countries was considerably lagging behind developments in North America, with the topic of malingering being largely taboo for psychological and medical professionals. This was being changed in the course of the past decade with a growing interest in methods for the assessment of negative response bias. European estimates of suboptimal test performance in civil and social forensic contexts point at base rates similar to those obtained in North America. Symptom over-reporting and underperformance in neuropsychological examinations appear to occur in a sizable proportion of patients. Although there is considerable progress in establishing SVA as an integral and indispensable part of psychological and neuropsychological assessment in some countries, others appear to lag behind. In some countries there is still enormous resistance against SVA from part of the neuropsychological and psychiatric communities.

Palabras clave : Symptom validity assessment; Malingering; Performance validity tests; History.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )